Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Prophylactic laser versus continued surveillance after initial bevacizumab treatment for retinopathy of prematurity

Journal of American Association for Pediatric Ophthalmology and Strabismus(2021)10.1016/j.jaapos.2021.02.002Source: DataRank Database

Prophylactic laser versus continued surveillance after initial bevacizumab treatment for retinopathy of prematurity is a research paper published in Journal of American Association for Pediatric Ophthalmology and Strabismus (2021). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 0.25)OA: greenTopics (27)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Sandra S. Stinnett ORCID,Sharon F. Freedman ORCID,David K. Wallace ORCID,S. Grace Prakalapakorn ORCID,Gloria J. Hong ORCID

Live enrichment

PubMed:33964453 OpenAlex:https://openalex.org/W3158385949

National Institutes of Health

Grant: UG1 EY011751

FWCI

0.25

Citation Percentile

0.5%

Citation Trend

2022

2026

greenLicense: other-oa

repositoryhttps://hdl.handle.net/1805/26779

publisherhttps://api.elsevier.com/content/article/PII:S1091853121000975?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1091853121000975?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jaapos.2021.02.002

Fields of Study

Retinopathy of Prematurity StudiesNeonatal Respiratory Health ResearchCardiovascular Conditions and Treatments

MeSH Terms

BevacizumabGestational AgeHumansInfantInfant, NewbornLasersRetinopathy of PrematurityLaser CoagulationAngiogenesis InhibitorsVascular Endothelial Growth Factor AIntravitreal Injections

Keywords

MedicineRetinopathy of prematurityBevacizumabPediatricsOutpatient clinicVascular endothelial growth factorOphthalmologyVEGF receptorsSurgeryInternal medicineChemotherapyGestational agePregnancy

Sustainable Development Goals

SDG 0: Good health and well-being